This clinical trial is focused on studying the treatment of asthma, a condition that affects the airways in the lungs, making it difficult to breathe. The study will use a medication called Mepolizumab, which is designed to help control asthma symptoms. Mepolizumab is administered in two different ways: one group of patients will receive it through a pre-filled syringe given by a nurse, while another group will use an auto-injector pen to self-administer the medication. The purpose of the study is to compare how well patients adhere to their treatment and how effectively their asthma is controlled over a period of six months.
Participants in the study will be monitored for a total of 12 months. During this time, they will receive Mepolizumab injections once a month. The study will assess how well patients follow their treatment plan and how their asthma symptoms are managed. Patients will be asked to keep a diary to track their medication use and asthma symptoms. The study will also compare the proportion of patients who have their asthma under control after six months of treatment.
Throughout the study, various assessments will be conducted to evaluate the effectiveness of the treatment. These assessments include measuring asthma control using a questionnaire called the ACT score, monitoring any asthma exacerbations, and evaluating the need for additional medical consultations. The study will also collect information on any side effects experienced by participants. The goal is to determine which method of administering Mepolizumab is more effective in helping patients manage their asthma symptoms and adhere to their treatment plan.
France 
